Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
KY/TN Water Profession...KY/TN Water Professionals
Not Confirmed
Not Confirmed
27-30 July, 2025
Chemicals AmericaChemicals America
Not Confirmed
Not Confirmed
29-31 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
KY/TN Water Profession...KY/TN Water Professionals
Industry Trade Show
Not Confirmed
27-30 July, 2025
Chemicals AmericaChemicals America
Industry Trade Show
Not Confirmed
29-31 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
23 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/23/3103112/0/en/Enterome-presents-positive-Phase-2-interim-results-in-relapsed-refractory-indolent-non-Hodgkin-lymphoma-after-EO2463-OncoMimics-immunotherapy-treatment-at-ICML.html
12 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/12/3098067/0/en/Enterome-raises-19-million-to-fund-clinical-development-of-its-OncoMimics-immunotherapy-to-treat-Follicular-Lymphoma.html
02 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/02/3091776/0/en/Enterome-to-present-positive-Phase-2-indolent-non-Hodgkin-lymphoma-data-for-its-OncoMimics-EO2463-at-ICML.html
30 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/30/3090836/0/en/Enterome-presents-positive-Phase-1-2-MSS-pMMR-metastatic-colorectal-cancer-data-in-patients-treated-with-EO4010-OncoMimics-immunotherapy-plus-nivolumab-at-ASCO-2025.html
11 Dec 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/12/11/2995198/0/en/Enterome-Presents-Encouraging-Initial-Clinical-Data-on-EO4010-in-Colorectal-Cancer-at-ESMO-IO-2024.html
10 Dec 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/12/10/2994785/0/en/Enterome-s-Immunotherapy-EO2463-Shows-Early-Clinical-Response-in-Newly-Diagnosed-Follicular-Lymphoma-Suggesting-a-Potential-Alternative-to-Watchful-Waiting.html
ABOUT THIS PAGE